Sentences with phrase «advanced translational research»

As such, he «very much enjoys the collaborative, clinical environment and the opportunity to advance translational research in mood and anxiety - related disorders.»

The SMA Foundation has been instrumental in raising awareness and supporting ground breaking SMA projects in biotechnology, government and academia which will advance translational research overall, including the efforts underway at NIH.

Not exact matches

The latest research in Science Translational Medicine, covering advances toward the goal of improving patients» lives.

The NIH continues to promote translational research with the creation of the National Center for Advancing Translational Sciences (NCATS) as a «bold, new, focused center systematically engineered to accelerate transltranslational research with the creation of the National Center for Advancing Translational Sciences (NCATS) as a «bold, new, focused center systematically engineered to accelerate translTranslational Sciences (NCATS) as a «bold, new, focused center systematically engineered to accelerate translation.»

A clinical trial conducted by researchers at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen), showed that a new drug called MM - 398, given in combination with 5 - flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously - treated pancreatic cancer.

The Sartorius & Science Prize for Regenerative Medicine & Cell Therapy is an annual prize geared toward researchers focused on basic or translational research that advances regenerative medicine and cell therapy.

Research reported in this news release was supported by the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) under award number R01 HL116585 - 01 and the National Center for Advancing Translational Sciences of the NIH under award numbers UL1TR000075 and KL2TR000076.

Last year, when NIH's National Center for Research Resources was disbanded, the CTSA program migrated to the new National Center for Advancing Translational Sciences (NCATS).

► «To facilitate communication among scientists, physicians, and veterinarians, a paradigm of «one literature» can raise cross-species awareness and bring together new research communities and collaborations that advance translational medicine,» wrote Mary M. Christopher of the School of Veterinary Medicine at the University of California, Davis, in this week's issue of STM.

«We are excited by the work of Dr. Pourdehnad and colleagues and believe these results are an important advance in understanding the role of myc pathway dysregulation in multiple myeloma, and ultimately allow for the development of therapeutic strategies to address it,» said Jeffrey Wolf, MD, a UCSF blood disorder specialist and director of the Stephen and Nancy Grand Multiple Myeloma Translational Initiative at UCSF, a sponsor of the research.

The journal's home page explains that translational medicine «builds on basic research advances — studies of biological processes using cell cultures, for example, or animal models — and uses them to develop new therapies or medical procedures.»

Her research is both translational and clinical in nature and centers on the human genetics of healthy skin aging and diseases related to aging skin, including new treatments for advanced basal cell skin cancers.

The bill does not mention NIH's plan to create a National Center for Advancing Translational Sciences (NCATS) and to abolish the National Center for Research Resources (NCRR).

The life cycle of a medical advance usually goes something like this: from discovery at the research bench and replication of findings, to translational research and clinical trials, to implementation.

Researchers at the Research Center Translational Neurosciences of Johannes Gutenberg University Mainz (JGU) in Germany have advanced a generalized concept as the basis for future studies of mental resilience.

Time will tell whether institutions and funding agencies will sustain support for translational research and continue to plumb the storehouse of basic biomedical advances to help sick people.

This advance in breast cancer research reflects the mission of Stem Cell Reports to provide an open - access forum that communicates basic discoveries in stem cell research as well as translational and clinical studies.

«I think the general thought process is: «These patients are not going to live long,»» said Dr. Mammen, Director of Translational Research for UT Southwestern's Advanced Heart Failure Program.

This webinar will focus on what Denmark is doing in the area of translational medicine to advance research, strengthen ties between academia and industry, and provide a fertile environment for innovation and the practical application of new discoveries.

Temple Health Magazine highlights the people, activities and programs at the Lewis Katz School of Medicine and Temple University Health System that are advancing medical education, translational research and patient care.

By taking advantage of the excellent clinical environment coupled to the outstanding basic research carried out at Ospedale San Raffaele, the center will allow the Institute as a whole to advance towards integrative translational research.

About the Anna - Maria Kellen Clinical Accelerator The Anna - Maria Kellen Clinical Accelerator, the clinical research program of the Cancer Research Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innresearch program of the Cancer Research Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innResearch Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innresearch and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innresearch ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innovation.

Funding: NIH's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Heart, Lung, and Blood Institute (NHLBI), National Institute on Aging (NIA), National Center for Advancing Translational Sciences (NCATS), National Cancer Institute (NCI), and National Human Genome Research Institute (NHGRI); and many other funding entities (see reference paper for the full list).

Advancing the Exosome Extracellular Vesicle into the Mainstream Thomas Temple, M.D. — NSU senior vice president, translational research and economic development; executive associate dean for research, NSU M.D. College

At the dinner, Parker also received the organization's highest honor for lay individuals, the Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research, for his outspoken endorsement of cancer immunotherapy and substantial financial support of the Cancer Immunology Translational Research Dream Team that is jointly funded by CRI and Stand Up To Cancer, an organization to which Parker has strong ties.

The Clinical Accelerator, building on 60 + years of CRI's dedication to funding the most innovative basic science in tumor immunology, enables experts to advance their most ambitious clinical and translational research ideas to cure cancer, and accelerates studies that one group or company could not do alone.

The Center for Advanced Laboratory Medicine (CALM) opens, with high - tech diagnostic services for clinically applied translational research.

Over the past three years, Ramot has provided more than $ 40M to translational research through value enhancement programs, helping Tel Aviv University researchers advance their research through the best possible routes, and providing companies and investors with access to cutting - edge technologies and research.

Soil Microbiology Research in the Coming Decades: Translational Research Opportunities — Tapan Kumar Adhya — Advances in Soil Microbiology: Recent Trends and Future Prospects

Our cutting - edge laboratory, clinical, and translational research programs are advancing the frontiers of surgical care.

The work was supported by the Salk Institute's Dulbecco Center for Cancer Research, the Adler Family Foundation, the Ahmanson Translational Imaging Division at UCLA, the National Center for Advancing Translational Sciences, the National Institutes of Health, the American Cancer Society, the Samuel Waxman Cancer Research Foundation, the Howard Hughes Medical Institute and the Leona M. and Harry B. Helmsley Charitable Trust.

Our clinicians work closely with our scientists on basic, clinical, and translational research activities in an effort to advance our understanding of these unique tumors.

SMR contributes to advances in melanoma research by catalyzing collaborations among basic, translational, and clinical researchers, carrying new technology - based discoveries from bench to bedside and back.

And more than 70 years later, Cleveland Clinic and the Lerner Research Institute are at the forefront of advanced techniques and biological discovery, emphasizing translational research that has the potential to change the way we practice mResearch Institute are at the forefront of advanced techniques and biological discovery, emphasizing translational research that has the potential to change the way we practice mresearch that has the potential to change the way we practice medicine.

The work and the researchers involved were supported by grants from the Dystonia Coalition, the Office of Rare Diseases Research at the National Center for Advancing Translational Sciences and the National Institute of Neurological Disorders and Stroke, the Bachmann - Strauss Dystonia & Parkinson Foundation, the Benign Essential Blepharospasm Research Foundation, the Kavli Institute for Brain and Mind at UCSD, the National Institute of Mental Health, and the National Science Foundation.

The IACS and CCCT Moon Shot ™ platforms will continue to provide drug development and translational research as the Navire programs advance towards clinical testing.

He is a pediatric oncologist with an active clinical and translational research program focused on patients with advanced neuroblastoma and Ewing sarcoma.

On May 22, 2008 Mount Vernon Middle School Career Day Rebecca Mitchell, M.S.N., C.N.S. spoke to approximately 250 students, teachers and community members about various career opportunities available in the genetic research community, including nursing, advanced practice nursing, bioinformatics, genetic counseling and translational research.

Funding: NIH's National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Neurological Disorders and Stroke (NINDS), and National Center for Advancing Translational Sciences (NCATS); Italian Ministry of Health; Associazione Italiana Encefalopatie da Prioni; La Fondation pour la Recherche Médicale; U.K. Department of Health, Scottish Government; Etablissement Français du Sang; Alliance Biosecure Foundation, INSERM, Institut de Veille Sanitaire, program Investissements d'avenir; and U.K. Department of Health Policy Research Programme.

MD Anderson's Institute for Applied Cancer Science (IACS) in combination with Deerfield will provide drug discovery and development expertise, together with translational research focused at advancing autophagy therapeutics into trials in melanoma, lung and pancreatic cancers.

Funding Research reported in this news release was supported by the National Center for Advancing Translational Sciences (award number 1 - UG3 - NS -105703-01) and the National Institute of Diabetes and Digestive and Kidney Diseases (award number R56DK106202 - 01) of the National Institutes of Health: the Cedars - Sinai Board of Governors Regenerative Medicine Institute; the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute; and the Drown Foundation.

Funding was provided by the National Institute of Allergy and Infectious Diseases, the National Science Foundation Graduate Research Fellowship Program, the National Science Foundation Stem Cell Biomanufacturing Integrative Graduate Education and Research Traineeship Program, and the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF - CTSI UL 1 TR000004.

The Ogawa - Yamanaka Stem Cell Prize recognizes individuals whose original translational research has advanced cellular reprogramming technology for regenerative medicine.

Location: NC1 - 202 Title: «Brain Metastases - Our Advances and Failures» The Department of Cellular and Molecular Medicine welcomes guest speaker Dr. Paul R. Lockman, Professor and Chair Basic Pharmaceutical Sciences, Associate Center Director for Translational Research, West Virginia University Cancer Institute.

We identify and advance therapeutics into clinical trials for children with brain cancer, with increasing focus on types of brain tumors that are uncommon and have the greatest need for translational research.

In this eBook, we examine the complexity of the tumor microenvironment, explore technologies that are innovating basic and translational research, and strategies that are advancing immunotherapy into the clinic.

Our goal is to advance scientific knowledge while simultaneously nourishing translational research to provide advances in the domains of prevention, screening, diagnosis, and treatment of cancer.

In addition, I work closely with colleagues in Lineberger on innovative clinical trials and translational research projects directed at developing novel strategies for the treatment of advanced disease.

Clinical Accelerator fosters a collaborative environment that enables scientists to advance their most ambitious clinical and translational research ideas, and accelerates studies that one group or company could not do alone.

Clemson University's Institute of Translational Genomics has been awarded $ 6 million by Advanced Research Projects Agency - Energy as one of six Transportation Energy Resources for Renewable Agriculture (TERRA) projects totaling $ 30 million that are seeking to accelerate the development of sustainable energy crops for the production of renewable transportation fuels.